Skip to content

Comparation Of Ketorolac And Methadone

Comparation Of Ketorolac And Methadone Effect In Postoperative Pain Control Of Plating’s Orthopedic Surgery

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190731044395N1
Enrollment
120
Registered
2020-07-21
Start date
2019-12-06
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients candidate for orthopedic Plating’s Surgery.

Interventions

Intervention 1: Intervention group 1: Ketorolac group. Intervention 2: Intervention group 2: Methadone group.

Sponsors

Zahedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 55 Years

Inclusion criteria

Inclusion criteria: AGE 15-55years No underlying disease ASA CLASS I&II General anesthesia Plating’s Orthopedic Surgery’s cases

Exclusion criteria

Exclusion criteria: Drug addict Preoperative hemodynamic unstability Blood loss that needs Transfusion of Packed Red Cells Take a drug that effects on hemodynamic Informed consent not signed

Design outcomes

Primary

MeasureTime frame
Reduced pain score in patients. Timepoint: Pain will be evaluated at the beginning of study and 0.5, 1 and 6 hours after intervention. Method of measurement: Visual acuity scale.;Heart rate. Timepoint: Pain will be evaluated at the beginning of study and 0.5, 1 and 6 hours after intervention. Method of measurement: Heart contraction by ECG monitor.;Blood pressure. Timepoint: Pain will be evaluated at the beginning of study and 0.5, 1 and 6 hours after intervention. Method of measurement: Blood pressure on monitor.;Nausea & Vomit. Timepoint: Pain will be evaluated at the beginning of study and 0.5, 1 and 6 hours after intervention. Method of measurement: Asking Patient.;Asking for morphine. Timepoint: Pain will be evaluated at the beginning of study and 0.5, 1 and 6 hours after intervention. Method of measurement: Number of doses patient asking for.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSomayye heidarpour

Zahedan University of Medical Sciences

enayati45hassan@gmail.com+98 54 3325 4293

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026